Cytokinetics, Incorporated · NASDAQ:CYTK
Callos Andrew sold 14,000 Cytokinetics, Incorporated shares (Form 4)
Traded Jul 30, 2026 · Filed Jul 30, 2026
On Jul 30, 2026, Callos Andrew (EVP, Chief Commercial Officer) sold 14,000 Cytokinetics, Incorporated shares at US$79.88 for US$1.12M under a trading plan, leaving 58,555 shares. Filed Jul 30, 2026 (Form 4).
- Sold
- 14,000 shares
- Price
- US$79.88
- Value
- US$1.12M
- Holding after
- 58,555 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- EVP, Chief Commercial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jul 30, 2026 | Common Stock | Option exercise | 14,000 | US$23.26 | 72,555 | Direct |
| Jul 30, 2026 | Common Stock | Sale | 14,000 | US$79.88 | 58,555 | Direct |
Source
Related
- Cytokinetics, Incorporated
- Callos Andrew
- Cytokinetics, Incorporated shareholders
- Form 4 · Callos Andrew · Aug 31, 2026
- Form 4 · Callos Andrew · Jul 2, 2026
- Form 4 · Callos Andrew · Jun 1, 2026
- Form 4 · Callos Andrew · May 5, 2026
- Form 4 · Callos Andrew · May 4, 2026
- Form 4 · Malik Fady Ibraham · Oct 20, 2026
- Form 4 · Daly James M · Oct 20, 2026
- Form 4 · Henderson John T · Oct 20, 2026
- Form 4 · Wysenski Nancy · Oct 20, 2026
- Form 4 · Harrington Robert Arthur · Oct 20, 2026